We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TECHNE (Tech): "selling picks to gold miners"
TECH 77.31+1.2%Jul 12 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: mopgcw8/26/2006 4:19:36 AM
   of 46
Techne helps finance biopharmaceutical company
Friday August 25, 4:12 pm ET

Techne Corp. has invested in a California biopharmaceutical company that recently signed a $63.5 million deal with GlaxoSmithKline.
Techne was one of six companies to invest in Mountain View-based ChemoCentryx, which netted $17.1 million in its third round of financing.

ChemoCentryx is a clinical-stage biopharmaceutical company focused on orally-administered therapeutics for autoimmune diseases, inflammatory disorders and cancer.

Minneapolis-based Techne (Nasdaq: TECH - News) is a biotech firm that makes kits of proteins and antibodies that are sold to biomedical researchers.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext